Laboratory Corporation of America Statistics
Share Statistics
Laboratory Corporation of America has 83.64M shares outstanding. The number of shares has increased by -0.55% in one year.
| Shares Outstanding | 83.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.39% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 83.35M |
| Failed to Deliver (FTD) Shares | 750 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 1.97M, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 1.97M |
| Short % of Shares Out | 2.35% |
| Short % of Float | 2.36% |
| Short Ratio (days to cover) | 3.31 |
Valuation Ratios
The PE ratio is 47.36 and the forward PE ratio is 15.25.
| PE Ratio | 47.36 |
| Forward PE | 15.25 |
| PS Ratio | 1.63 |
| Forward PS | null |
| PB Ratio | 2.51 |
| P/FCF Ratio | 22.65 |
| PEG Ratio | n/a |
Enterprise Valuation
Laboratory Corporation of America has an Enterprise Value (EV) of 25.21B.
| EV / Earnings | 60.32 |
| EV / Sales | 2.07 |
| EV / EBITDA | 18.69 |
| EV / EBIT | 34.75 |
| EV / FCF | 28.85 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.17 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.76 |
| Total Debt / Capitalization | 43.06 |
| Cash Flow / Debt | 0.22 |
| Interest Coverage | 3.64 |
Financial Efficiency
Return on equity (ROE) is 0.05% and return on capital (ROIC) is 3.5%.
| Return on Equity (ROE) | 0.05% |
| Return on Assets (ROA) | 0.02% |
| Return on Capital (ROIC) | 3.5% |
| Revenue Per Employee | 181.52K |
| Profits Per Employee | 6.24K |
| Employee Count | 67.00K |
| Asset Turnover | 0.73 |
| Inventory Turnover | 18.53 |
Taxes
| Income Tax | 188.50M |
| Effective Tax Rate | 0.33 |
Stock Price Statistics
The stock price has increased by 5.77% in the last 52 weeks. The beta is 1.04, so Laboratory Corporation of America's price volatility has been higher than the market average.
| Beta | 1.04 |
| 52-Week Price Change | 5.77% |
| 50-Day Moving Average | 234.36 |
| 200-Day Moving Average | 218.2 |
| Relative Strength Index (RSI) | 55.43 |
| Average Volume (20 Days) | 603.25K |
Income Statement
In the last 12 months, Laboratory Corporation of America had revenue of 12.16B and earned 418.00M in profits. Earnings per share was 4.8.
| Revenue | 12.16B |
| Gross Profit | 3.36B |
| Operating Income | 725.60M |
| Net Income | 418.00M |
| EBITDA | 1.35B |
| EBIT | 725.60M |
| Earnings Per Share (EPS) | 4.8 |
Balance Sheet
The company has 536.80M in cash and 5.95B in debt, giving a net cash position of -5.42B.
| Cash & Cash Equivalents | 536.80M |
| Total Debt | 5.95B |
| Net Cash | -5.42B |
| Retained Earnings | 7.89B |
| Total Assets | 18.61B |
| Working Capital | 1.50B |
Cash Flow
In the last 12 months, operating cash flow was 1.33B and capital expenditures -453.60M, giving a free cash flow of 874.10M.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -453.60M |
| Free Cash Flow | 874.10M |
| FCF Per Share | 10.04 |
Margins
Gross margin is 27.67%, with operating and profit margins of 5.97% and 3.44%.
| Gross Margin | 27.67% |
| Operating Margin | 5.97% |
| Pretax Margin | 4.68% |
| Profit Margin | 3.44% |
| EBITDA Margin | 11.1% |
| EBIT Margin | 5.97% |
| FCF Margin | 7.19% |
Dividends & Yields
LH pays an annual dividend of $2.88, which amounts to a dividend yield of 1.23%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 1.23% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 54.65% |
| Earnings Yield | 2.05% |
| FCF Yield | 4.46% |
Analyst Forecast
The average price target for LH is $257.5, which is 9.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $257.5 |
| Price Target Difference | 9.8% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
Stock Splits
The last stock split was on Jul 3, 2023. It was a forward split with a ratio of 291:250.
| Last Split Date | Jul 3, 2023 |
| Split Type | forward |
| Split Ratio | 291:250 |
Scores
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 7 |